Lilly To Try ProQR’s RNA-Editing Technology In Liver, Neurology Indications

 
• By Joseph Haas
  
Innovation concept presented by a consultant in management on webinar screen
Lilly decides to tap into ProQR's RNA-editing technology

More from Deals

More from Business